Nicola Fiotti Selected Research

Hypoxia (Hypoxemia)

1/2018

Effects of Hypoxia and Bed Rest on Markers of Cardiometabolic Risk: Compensatory Changes in Circulating TRAIL and Glutathione Redox Capacity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicola Fiotti Research Topics

Disease

7	Sepsis (Septicemia) 01/2022 - 06/2013
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 03/2011
5	Inflammation (Inflammations) 01/2022 - 08/2007
4	Insulin Resistance 12/2023 - 01/2018
4	Abdominal Aortic Aneurysm 05/2022 - 09/2002
4	Hepatocellular Carcinoma (Hepatoma) 01/2017 - 08/2007
4	Acute Coronary Syndrome 05/2009 - 10/2002
3	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 05/2022 - 10/2014
3	Atherosclerosis 01/2022 - 08/2008
3	Neoplasms (Cancer) 01/2018 - 06/2013
3	Stable Angina 07/2008 - 10/2002
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023 - 10/2002
2	Infections 05/2022 - 01/2018
2	COVID-19 01/2022 - 08/2021
2	Aneurysm (Aneurysms) 01/2018 - 09/2002
2	Stroke (Strokes) 03/2011 - 09/2010
2	Non-ST Elevated Myocardial Infarction 03/2011 - 08/2007
2	Unstable Angina 08/2007 - 10/2002
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2023
1	Peripheral Arterial Disease 01/2023
1	Hypercholesterolemia 01/2023
1	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 11/2022
1	Endoleak 05/2022
1	Thrombocytopenia (Thrombopenia) 01/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022
1	Liver Diseases (Liver Disease) 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Muscular Atrophy (Muscle Atrophy) 01/2022
1	Dyslipidemias (Dyslipidemia) 10/2021
1	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 10/2021
1	Myotoxicity 10/2021
1	Fatigue 10/2021
1	Muscular Diseases (Myopathy) 10/2021
1	Rhabdomyolysis 10/2021
1	Myalgia 10/2021
1	Pneumonia (Pneumonitis) 08/2021
1	Myocardial Infarction 04/2019
1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 01/2019
1	Cachexia 01/2019
1	Leukocytosis (Pleocytosis) 01/2018
1	Hypoglycemia (Reactive Hypoglycemia) 01/2018
1	Hyperglycemia 01/2018
1	Hyperthermia 01/2018
1	Septic Shock (Toxic Shock Syndrome) 01/2018

Drug/Important Bio-Agent (IBA)

10	Matrix Metalloproteinases (MMPs)IBA 05/2022 - 09/2002
8	Biomarkers (Surrogate Marker)IBA 05/2022 - 05/2009
5	Proteins (Proteins, Gene)FDA Link 12/2023 - 06/2013
4	ProcalcitoninIBA 01/2018 - 06/2013
4	C-Reactive ProteinIBA 01/2018 - 10/2002
3	Group II Phospholipases A2IBA 01/2018 - 06/2013
3	CyclinsIBA 01/2014 - 08/2007
2	Lipoprotein(a)IBA 01/2023 - 01/2023
2	oxidized low density lipoproteinIBA 01/2023 - 01/2023
2	Metalloproteases (Metalloproteinases)IBA 05/2022 - 06/2016
2	Therapeutic UsesIBA 01/2022 - 06/2013
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 04/2021
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 01/2018
2	Glutathione (Reduced Glutathione)IBA 01/2018 - 01/2018
2	Phospholipases A2 (Phospholipase A2)IBA 10/2014 - 06/2013
2	Tissue Inhibitor of Metalloproteinase-1IBA 07/2008 - 08/2007
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 08/2007 - 10/2002
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 03/2007 - 06/2006
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 04/2005 - 07/2004
1	Leucine (L-Leucine)FDA Link 12/2023
1	LDL CholesterolIBA 01/2023
1	growth arrest-specific protein 6IBA 01/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022
1	LigandsIBA 01/2022
1	AnticoagulantsIBA 01/2022
1	ATP Citrate (pro-S)-Lyase (Citrate Synthase, ATP)IBA 01/2022
1	8- hydroxy- 2,2,14,14- tetramethylpentadecanedioic acidIBA 01/2022
1	Branched-Chain Amino AcidsIBA 01/2022
1	LipidsIBA 01/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	Triglycerides (Triacylglycerol)IBA 01/2022
1	AMP-Activated Protein KinasesIBA 01/2022
1	Hypolipidemic Agents (Antihyperlipidemics)IBA 10/2021
1	Creatine Kinase (Creatine Phosphokinase)IBA 10/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2021
1	Nucleic AcidsIBA 08/2021
1	AntioxidantsIBA 04/2021
1	Galectin 3 (LGALS3)IBA 04/2019
1	Carrier Proteins (Binding Protein)IBA 04/2019
1	CarbohydratesIBA 01/2019
1	Muscle Proteins (Muscle Protein)IBA 01/2019
1	HDL CholesterolIBA 01/2018
1	Insulin (Novolin)FDA Link 01/2018
1	Lipase (Acid Lipase)FDA Link 01/2018
1	serum P-component (CIt)IBA 01/2018
1	HomocysteineIBA 01/2018
1	TNF-Related Apoptosis-Inducing LigandIBA 01/2018

Therapy/Procedure

9	Therapeutics 10/2021 - 08/2007
4	Bed Rest (Bedrest) 12/2023 - 01/2018
2	High-Protein Diet 12/2023 - 01/2022
2	Photochemotherapy (Photodynamic Therapy) 03/2007 - 06/2006
1	Endovascular Aneurysm Repair 05/2022
1	Secondary Prevention 10/2021
1	Radiotherapy 01/2018
1	Total Parenteral Nutrition 01/2018